Guardant Historical Income Statement

GH Stock  USD 17.96  0.27  1.53%   
Historical analysis of Guardant Health income statement accounts such as Interest Income of 37.1 M can show how well Guardant Health performed in making a profits. Evaluating Guardant Health income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Guardant Health's future profits or losses.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Guardant Health latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Guardant Health is a good buy for the upcoming year.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.

About Guardant Income Statement Analysis

Guardant Health Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Guardant Health shareholders. The income statement also shows Guardant investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Guardant Health Income Statement Chart

Guardant Health Income Statement is one of the three primary financial statements used for reporting Guardant's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Guardant Health revenue and expense. Guardant Health Income Statement primarily focuses on the company's revenues and expenses during a particular period.
As of now, Guardant Health's Depreciation And Amortization is increasing as compared to previous years. The Guardant Health's current Interest Expense is estimated to increase to about 2.8 M, while Selling General Administrative is projected to decrease to under 118.7 M.

Total Revenue

Total revenue comprises all receipts Guardant Health generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Guardant Health minus its cost of goods sold. It is profit before Guardant Health operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.
Most accounts from Guardant Health's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Guardant Health current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.As of now, Guardant Health's Depreciation And Amortization is increasing as compared to previous years. The Guardant Health's current Interest Expense is estimated to increase to about 2.8 M, while Selling General Administrative is projected to decrease to under 118.7 M.
 2021 2022 2023 2024 (projected)
Gross Profit250.7M293.2M336.9M177.0M
Total Revenue373.7M449.5M563.9M282.4M

Guardant Health income statement Correlations

0.20.24-0.250.450.440.530.410.390.51-0.62-0.65-0.620.56-0.650.490.52-0.65-0.07-0.651.0-0.670.49-0.6
0.21.00.42-0.170.50.610.690.660.64-0.73-0.61-0.730.76-0.650.890.62-0.610.68-0.610.2-0.460.7-0.73
0.241.00.42-0.110.510.610.690.660.65-0.74-0.62-0.740.76-0.660.890.63-0.620.68-0.620.24-0.480.71-0.73
-0.250.420.420.03-0.01-0.22-0.05-0.07-0.110.060.260.06-0.060.210.14-0.130.250.940.26-0.250.15-0.130.25
0.45-0.17-0.110.030.17-0.09-0.06-0.05-0.02-0.02-0.03-0.02-0.04-0.01-0.05-0.01-0.02-0.01-0.030.45-0.18-0.070.07
0.440.50.51-0.010.170.840.90.930.9-0.85-0.84-0.850.84-0.840.770.91-0.840.13-0.840.44-0.920.81-0.45
0.530.610.61-0.22-0.090.840.970.960.99-0.94-0.96-0.940.94-0.960.870.99-0.960.03-0.960.53-0.890.99-0.79
0.410.690.69-0.05-0.060.90.971.00.99-0.93-0.91-0.930.93-0.920.890.99-0.910.18-0.910.41-0.870.98-0.7
0.390.660.66-0.07-0.050.930.961.00.99-0.92-0.91-0.920.92-0.910.880.99-0.910.15-0.910.39-0.880.96-0.67
0.510.640.65-0.11-0.020.90.990.990.99-0.95-0.94-0.950.94-0.950.881.0-0.940.12-0.940.51-0.910.98-0.73
-0.62-0.73-0.740.06-0.02-0.85-0.94-0.93-0.92-0.950.981.0-0.990.99-0.96-0.950.98-0.220.98-0.620.93-0.940.82
-0.65-0.61-0.620.26-0.03-0.84-0.96-0.91-0.91-0.940.980.98-0.971.0-0.9-0.951.0-0.011.0-0.650.94-0.930.83
-0.62-0.73-0.740.06-0.02-0.85-0.94-0.93-0.92-0.951.00.98-0.990.99-0.96-0.950.98-0.220.98-0.620.93-0.940.82
0.560.760.76-0.06-0.040.840.940.930.920.94-0.99-0.97-0.99-0.980.970.94-0.970.22-0.970.56-0.910.94-0.83
-0.65-0.65-0.660.21-0.01-0.84-0.96-0.92-0.91-0.950.991.00.99-0.98-0.92-0.951.0-0.071.0-0.650.93-0.940.84
0.490.890.890.14-0.050.770.870.890.880.88-0.96-0.9-0.960.97-0.920.88-0.90.42-0.90.49-0.810.9-0.83
0.520.620.63-0.13-0.010.910.990.990.991.0-0.95-0.95-0.950.94-0.950.88-0.950.1-0.950.52-0.920.98-0.72
-0.65-0.61-0.620.25-0.02-0.84-0.96-0.91-0.91-0.940.981.00.98-0.971.0-0.9-0.95-0.011.0-0.650.94-0.930.83
-0.070.680.680.94-0.010.130.030.180.150.12-0.22-0.01-0.220.22-0.070.420.1-0.01-0.01-0.07-0.050.14-0.08
-0.65-0.61-0.620.26-0.03-0.84-0.96-0.91-0.91-0.940.981.00.98-0.971.0-0.9-0.951.0-0.01-0.650.94-0.930.83
1.00.20.24-0.250.450.440.530.410.390.51-0.62-0.65-0.620.56-0.650.490.52-0.65-0.07-0.65-0.670.49-0.6
-0.67-0.46-0.480.15-0.18-0.92-0.89-0.87-0.88-0.910.930.940.93-0.910.93-0.81-0.920.94-0.050.94-0.67-0.840.61
0.490.70.71-0.13-0.070.810.990.980.960.98-0.94-0.93-0.940.94-0.940.90.98-0.930.14-0.930.49-0.84-0.82
-0.6-0.73-0.730.250.07-0.45-0.79-0.7-0.67-0.730.820.830.82-0.830.84-0.83-0.720.83-0.080.83-0.60.61-0.82
Click cells to compare fundamentals

Guardant Health Account Relationship Matchups

Guardant Health income statement Accounts

201920202021202220232024 (projected)
Tax Provision(1.9M)379K300K1.1M685K719.3K
Net Interest Income12.6M5.4M1.4M3.5M32.8M34.4M
Interest Income13.7M10.2M3.9M6.1M35.4M37.1M
Depreciation And Amortization13.8M13.8M29.1M(106.5M)42.9M45.0M
Interest Expense1.3M1.2M4.8M2.6M2.6M2.8M
Selling General Administrative61.4M192.8M206.6M164.0M155.8M118.7M
Selling And Marketing Expenses78.3M106.5M191.9M299.8M295.2M149.0M
Total Revenue214.4M286.7M373.7M449.5M563.9M282.4M
Gross Profit143.7M194.2M250.7M293.2M336.9M177.0M
Other Operating Expenses296.7M541.7M784.7M993.9M1.1B566.9M
Operating Income(82.4M)(255.0M)(411.0M)(544.4M)(562.5M)(534.4M)
Net Income From Continuing Ops(67.9M)(246.3M)(384.8M)(654.6M)(479.4M)(455.5M)
Ebit(82.4M)(255.0M)(411.0M)(544.4M)(562.5M)(534.4M)
Research Development86.3M149.9M263.2M373.8M365.1M383.3M
Ebitda(68.5M)(241.1M)(381.9M)(650.9M)(519.6M)(493.7M)
Cost Of Revenue70.7M92.5M122.9M156.3M227.1M238.4M
Total Operating Expenses226.0M449.1M661.7M837.6M899.4M461.5M
Income Before Tax(69.7M)(245.9M)(384.5M)(653.4M)(478.8M)(454.8M)
Total Other Income Expense Net12.6M9.0M26.5M(109.1M)83.8M87.9M
Net Income Applicable To Common Shares(75.7M)(253.8M)(405.7M)(654.6M)(589.1M)(559.7M)
Net Income(67.9M)(246.3M)(384.8M)(654.6M)(479.4M)(455.5M)
Income Tax Expense(1.9M)379K300K1.1M685K719.3K
Reconciled Depreciation13.6M16.1M22.3M36.0M42.9M22.5M
Non Operating Income Net Other13.8M13.8M29.1M(106.5M)(95.8M)(91.1M)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Guardant Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Guardant Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Guardant Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Guardant Health Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.
Note that the Guardant Health information on this page should be used as a complementary analysis to other Guardant Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Guardant Stock analysis

When running Guardant Health's price analysis, check to measure Guardant Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Guardant Health is operating at the current time. Most of Guardant Health's value examination focuses on studying past and present price action to predict the probability of Guardant Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Guardant Health's price. Additionally, you may evaluate how the addition of Guardant Health to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Is Guardant Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.28)
Revenue Per Share
5.036
Quarterly Revenue Growth
0.222
Return On Assets
(0.18)
Return On Equity
(4.38)
The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.